HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prelabour rupture of the membranes at term and unfavourable cervix; a randomized placebo-controlled trial on early intervention with intravaginal prostaglandin E2 gel.

Abstract
Fifty nine women with prelabour rupture of membranes, unfavourable cervix and no evidence of infection or fetal distress were randomized formally to receive prostaglandin E2 (3mg) gel or sterile K-Y Jelly intravaginally. Conservative expectant management was followed for the next 24 hours. The subsequent management of the labour followed departmental protocol. The women who received prostaglandin went into labour sooner and were delivered earlier but the duration of labour was not significantly different. There were no significant differences in other clinical outcomes. There was 1 case of uterine rupture in the prostaglandin group. We conclude that early intervention with prostaglandin E2 gel intravaginally confers no advantage compared with conservative management except for earlier confinement in this group of patients.
AuthorsT Chung, M S Rogers, H Gordon, A Chang
JournalThe Australian & New Zealand journal of obstetrics & gynaecology (Aust N Z J Obstet Gynaecol) Vol. 32 Issue 1 Pg. 25-7 (Feb 1992) ISSN: 0004-8666 [Print] Australia
PMID1586330 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Gels
  • Placebos
  • Dinoprostone
Topics
  • Administration, Intravaginal
  • Adult
  • Dinoprostone (administration & dosage)
  • Female
  • Fetal Membranes, Premature Rupture (therapy)
  • Gels
  • Humans
  • Infant, Newborn
  • Labor, Induced
  • Placebos
  • Pregnancy
  • Pregnancy Outcome
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: